Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...
Weight loss drugs have risen in popularity in the recent years, but a disconnect remains between those who need the drugs and ...
Dr. Mehmet Furkan Burak said people who have lost weight and then gained it again can feel guilt or shame and blame ...
The quest for effective weight loss solutions has never been more urgent, with millions of people worldwide struggling to ...
Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on ...
Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...
"Coverage for these weight-loss drugs has significant cost implications for employers, as a previous KFF analysis estimated ...
"Because most people with obesity have elevated insulin levels, they develop insulin resistance, which contributes to weight gain. Semaglutide (or Ozempic) helps lower the levels of this fat-storing ...
Investigational once-weekly retatrutide yielded the greatest weight loss of all GLP-1 receptor agonists, up to 22.1% after 48 ...
Polls provide a useful window into understanding how Americans view their own weight and the recent availability of drugs ...
Study finds GLP-1 medications such as Ozempic could result in cuts to grocery spending and reductions in spending at ...
For overweight or obese individuals without diabetes, but with pre-existing cardiovascular disease, semaglutide (Ozempic, Wegovy) is not cost-effective at current pricing, new research shows.